Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Caffeine may help hair growth in hereditary hair loss.

The MtAnn3 gene affects root hair growth and is influenced by cytokinin.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

ADAM 10 and ADAM 12 proteins are involved in different stages of hair growth and could be targets for treating hair disorders.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Higher sulfotransferase enzyme levels predict better response to minoxidil for hair growth.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

The girl had a rare disorder causing mental and physical symptoms, with weak hair and unclear neurological issues.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

SOD1 and KL are promising targets for new hair loss treatments.

PLDζ2 and NPC4 have different roles in lipid changes and root hair growth in Arabidopsis under low phosphate, with PLDζ2 reducing root hair growth and NPC4 promoting it.

APKH in young males may signal early hair loss and needs early attention.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.